167 related articles for article (PubMed ID: 2445439)
21. Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat.
Ori C; Dam M; Pizzolato G; Battistin L; Giron G
Anesthesiology; 1986 Aug; 65(2):152-6. PubMed ID: 3740504
[TBL] [Abstract][Full Text] [Related]
22. Local cerebral glucose utilization in two models of B12 deficiency.
Hakim AM; Cooper BA; Rosenblatt DS; Pappius HM
J Neurochem; 1983 Apr; 40(4):1155-60. PubMed ID: 6834046
[TBL] [Abstract][Full Text] [Related]
23. Nalbuphine's reversal of hypovolemic shock in the anesthetized rat.
McKenzie JE; Anselmo DM; Muldoon SM
Circ Shock; 1985; 17(1):21-33. PubMed ID: 2996801
[TBL] [Abstract][Full Text] [Related]
24. The effects of apomorphine upon local cerebral glucose utilization in conscious rats and in rats anesthetized with chloral hydrate.
Grome JJ; McCulloch J
J Neurochem; 1983 Feb; 40(2):569-76. PubMed ID: 6822839
[TBL] [Abstract][Full Text] [Related]
25. Local cerebral glucose utilization during waking and slow wave sleep in the cat. A [14C]deoxyglucose study.
Petitjean F; Seguin S; Des Rosiers MH; Salvert D; Buda C; Janin M; Debilly G; Jouvet M; Bobillier P
Neurosci Lett; 1982 Sep; 32(1):91-7. PubMed ID: 7145230
[TBL] [Abstract][Full Text] [Related]
26. Ketamine effects on local cerebral blood flow and metabolism in the rat.
Cavazzuti M; Porro CA; Biral GP; Benassi C; Barbieri GC
J Cereb Blood Flow Metab; 1987 Dec; 7(6):806-11. PubMed ID: 3121648
[TBL] [Abstract][Full Text] [Related]
27. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
Kimes AS; London ED
J Pharmacol Exp Ther; 1989 Feb; 248(2):538-45. PubMed ID: 2918470
[TBL] [Abstract][Full Text] [Related]
28. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
[TBL] [Abstract][Full Text] [Related]
29. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
30. Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brain.
Hohmann AG; Matsumoto RR; Hemstreet MK; Patrick SL; Margulies JE; Hammer RP; Walker JM
Brain Res; 1992 Oct; 593(2):265-73. PubMed ID: 1450934
[TBL] [Abstract][Full Text] [Related]
31. Dependence and withdrawal following intracerebroventricular and systemic morphine administration: functional anatomy and behavior.
Adams RE; Wooten GF
Brain Res; 1990 Jun; 518(1-2):6-10. PubMed ID: 2390728
[TBL] [Abstract][Full Text] [Related]
32. Effects of oxotremorine on local glucose utilization in the rat cerebral cortex.
Dam M; Wamsley JK; Rapoport SI; London ED
J Neurosci; 1982 Aug; 2(8):1072-8. PubMed ID: 7108584
[TBL] [Abstract][Full Text] [Related]
33. Opioids with different affinity for subreceptors induce different effects on early and late sensory evoked potentials (SEP) in man.
Freye E; Buhl R; Ciaramelli F
NIDA Res Monogr; 1986; 75():551-4. PubMed ID: 2829001
[TBL] [Abstract][Full Text] [Related]
34. Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats.
Altarifi AA; Yuan Y; Zhang Y; Selley DE; Negus SS
Psychopharmacology (Berl); 2015 Feb; 232(4):815-24. PubMed ID: 25178814
[TBL] [Abstract][Full Text] [Related]
35. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
36. The analgetic effects of an intrathecally administered partial opiate agonist, nalbuphine hydrochloride.
Schmauss C; Doherty C; Yaksh TL
Eur J Pharmacol; 1982 Dec; 86(1):1-7. PubMed ID: 6897635
[TBL] [Abstract][Full Text] [Related]
37. Cardiorespiratory effects of nalbuphine and morphine premedication in adult cardiac surgical patients.
Lake CL; Duckworth EN; DiFazio CA; Magruder MR
Acta Anaesthesiol Scand; 1984 Jun; 28(3):305-9. PubMed ID: 6430010
[TBL] [Abstract][Full Text] [Related]
38. Effect of arterial PCO2 on 2-[1-14C]deoxy-D-glucose uptake by feline cerebral arteries.
Kostreva DR; McNeely J; Zuperku EJ
J Appl Physiol (1985); 1986 Oct; 61(4):1288-92. PubMed ID: 3096936
[TBL] [Abstract][Full Text] [Related]
39. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
40. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
